Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants

Go Back to All Clinical Trials

Neonatal saliva and urine exosomes as non-invasive biomarkers for neonatal outcomes in preterm infants

Brief description of study

The purpose of this study is to evaluate if biomarkers measured in body fluids (such as saliva, urine, and blood) and stool samples are associated with distinct neonatal diseases such as chronic lung disease of prematurity. Biomarkers are a measurable substance in body fluid that can predict the occurrence of a specific outcome, in this case, it will complications of prematurity such as lung disease. This is significant because findings could revolutionize the way preterm infants in neonatal intensive care units (NICUs) are monitored at the bedside.

Clinical Study Identifier: s19-01825

Principal Investigator: Nazeeh N Hanna.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies